Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI

Journal of the American Society of Nephrology

Volumn 27, Issue 1, 2016, Pages 44-48

  Okusa, Mark D ^a   Rosner, Mitchell H ^a   Kellum, John A ^b   Ronco, Claudio ^c  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ATRIAL NATRIURETIC FACTOR;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; ATHEROSCLEROSIS; CELL REGENERATION; CELLULAR IMMUNITY; COMORBIDITY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DRUG EFFICACY; FOLLOW UP; GENETIC STRAIN; HEMODYNAMICS; HUMAN; IMMUNITY; INFLAMMATION; KIDNEY FUNCTION; MULTICENTER STUDY (TOPIC); NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; VASCULAR DISEASE; ACUTE KIDNEY INJURY; ANIMAL; DISEASE MODEL;

ACUTE KIDNEY INJURY; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS;

EID: 84954456087     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015030233     Document Type: Article

References (42)

1. Star R: Design issues for clinical trials in acute renal failure. Blood Purif 19: 233-237, 2001
2. Molitoris BA, Okusa MD, Palevsky PM, Kimmel PL, Star RA: Designing clinical trials in acute kidney injury. Clin J AmSoc Nephrol 7: 842-843, 2012
3. Bonventre JV, Basile D, Liu KD, McKay D, Molitoris BA, Nath KA, Nickolas TL, Okusa MD, Palevsky PM, Schnellmann R, Rys-Sikora K, Kimmel PL, Star RA; Kidney Research National Dialogue (KRND): AKI: A path forward. Clin J Am Soc Nephrol 8: 1606-1608, 2013
4. Jo SK, Rosner MH, Okusa MD: Pharmacologic treatment of acute kidney injury: Why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol 2: 356-365, 2007
5. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA: Design of clinical trials in acute kidney injury: Report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol 7: 844-850, 2012
6. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V, Macleod MR: Can animal models of disease reliably inform human studies? PLoS Med 7: E1000245, 2010
7. Perrin S: Preclinical research: Make mouse studies work. Nature 507: 423-425, 2014
8. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, ZidekW: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180-184, 2000
9. Pannu N, Manns B, Lee H, Tonelli M: Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 65: 1366-1374, 2004
10. Sun Z, Fu Q, Cao L, Jin W, Cheng L, Li Z: Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: A metaanalysis of randomized, controlled trials. PLoS One 8: E55124, 2013
11. Chertow GM, Palevsky PM, Greene T: Studying the prevention of acute kidney injury: Lessons from an 18th-century mathematician. Clin J Am Soc Nephrol 1: 1124-1127, 2006
12. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BRC, Conger JD, Sayegh MH; Auriculin Anaritide Acute Renal Failure StudyGroup: Anaritide in acute tubular necrosis. N Engl J Med 336: 828-834, 1997
13. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeownW, O'shea M, Baughman R,Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, Pike M, Guler H-P: Multicenter clinical trial of recombinant human insulinlike growth factor I in patients with acute renal failure. Kidney Int 55: 2423-2432, 1999
14. MartinezMolinaD, JafariR, IgnatushchenkoM, Seki T, Larsson EA, Dan C, Sreekumar L, Cao Y, Nordlund P: Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341: 84-87, 2013
15. Marik PE: Low-dose dopamine: A systematic review. IntensiveCareMed 28: 877-883, 2002
16. Saotome T, Ishikawa K, May CN, Birchall IE, Bellomo R: The impact of experimental hypoperfusion on subsequent kidney function. Intensive Care Med 36: 533-540, 2010
17. Bajwa A, Huang L, Ye H, Dondeti K, Song S, Rosin DL, Lynch KR, Lobo PI, Li L, OkusaMD: Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. J Immunol 189: 2584-2596, 2012
18. Li L,Huang L, Ye H, Song SP, Bajwa A, Lee SJ, Moser EK, Jaworska K, Kinsey GR, Day YJ, Linden J, Lobo PI, Rosin DL, Okusa MD: Dendritic cells tolerizedwith adenosine A?AR agonist attenuate acute kidney injury. J Clin Invest 122: 3931-3942, 2012
19. Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22: 317-326, 2011
20. Day YJ, Huang L, Ye H, Linden J, Okusa MD: Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: Role of macrophages. Am J Physiol Renal Physiol 288: F722-F731, 2005
21. Renner B, Strassheim D, Amura CR, Kulik L, Ljubanovic D, Glogowska MJ, Takahashi K, Carroll MC, Holers VM, Thurman JM: B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion. J Immunol 185: 4393-4400, 2010
22. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB,O'DonnellMP, Rabb H: Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 108: 1283-1290, 2001
23. Li L, Huang L, Sung SS, Lobo PI, Brown MG, Gregg RK, Engelhard VH, Okusa MD: NKT cell activation mediates neutrophil IFNgamma production and renal ischemiareperfusion injury. J Immunol 178: 5899-5911, 2007
24. Bolisetty S, Agarwal A: Neutrophils in acute kidney injury: Not neutral any more. Kidney Int 75: 674-676, 2009
25. Awad AS, Rouse M, Huang L, Vergis AL, Reutershan J, Cathro HP, Linden J, Okusa MD: Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int 75: 689-698, 2009
26. Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Satpute SR, CrowMT, King LS, Rabb H: Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 76: 717-729, 2009
27. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD: Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J AmSoc Nephrol 20: 1744-1753, 2009
28. Tadagavadi RK, Reeves WB: Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J AmSoc Nephrol 21: 53-63, 2010
29. Yang SH, Lee JP, Jang HR, Cha RH, Han SS, Jeon US, Kim DK, Song J, Lee DS, Kim YS: Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury. J Am Soc Nephrol 22: 1305-1314, 2011
30. Price PM, Safirstein RL, Megyesi J: The cell cycle and acute kidney injury. Kidney Int 76: 604-613, 2009
31. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmelé T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA: Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17: R25, 2013
32. Zhan M, Brooks C, Liu F, Sun L, Dong Z: Mitochondrial dynamics: Regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int 83: 568-581, 2013
33. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370, 2005
34. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA 275: 1489-1494, 1996
35. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR: Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and metaanalysis. Am J Kidney Dis 53: 961-973, 2009
36. Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu CY: Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol 24: 37-42, 2013
37. Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordoñez JD, Hsu CY: Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76: 893-899, 2009
38. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20: 223-228, 2009
39. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG; University of Toronto Acute Kidney Injury Research Group: Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302: 1179-1185, 2009
40. Chawla LS, Eggers PW, Star RA, Kimmel PL: Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371: 58-66, 2014
41. Molitoris BA, Sutton TA: Endothelial injury and dysfunction: Role in the extension phase of acute renal failure. Kidney Int 66: 496-499, 2004
42. Sutton TA, Fisher CJ, Molitoris BA: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539-1549, 2002